top of page

Mike Cornejo


Hunter College

Radioimmunoconjugates has helped identify and treat various tumors by using a combination of antibodies, which selectively localize tumors, and radiometals, to delineate the tumor areas via PET imaging. Currently, I am developing new [64Cu]-labeled radioimmunoconjugates for colorectal cancer as well as novel approaches with fluorescent label immunoconjugates.

When not in the lab, I like to play soccer and follow european soccer matches and news. At the same time, every other weekend I like to cook different cousins and try new restaurants around the city.

Focus Area 2

Mike Cornejo
bottom of page